Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 381

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Adipsin Is an Adipokine that Improves β Cell Function in Diabetes

Open access
Lo, James C., Ljubicic, Sanda, Leibiger, Barbara, Kern, Matthias, Leibiger, Ingo B., Moede, Tilo, Kelly, Molly E., Chatterjee Bhowmick, Diti, Murano, Incoronata, Cohen, Paul, Banks, Alexander S., Khandekar, Melin J., Dietrich, Arne, Flier, Jeffrey S., Cinti, Saverio, Blüher, Matthias, Danial, Nika N., Berggren, Per-Olof, Spiegelman, Bruce M.·2014·Cell

Abstract

Summary A hallmark of type 2 diabetes mellitus (T2DM) is the development of pancreatic β cell failure, resulting in insulinopenia and hyperglycemia. We show that the adipokine adipsin has a beneficial role in maintaining β cell function. Animals genetically lacking adipsin have glucose intolerance due to insulinopenia; isolated islets from these mice have reduced glucose-stimulated insulin secretion. Replenishment of adipsin to diabetic mice treated hyperglycemia by boosting insulin secretion. We identify C3a, a peptide generated by adipsin, as a potent insulin secretagogue and show that the C3a receptor is required for these beneficial effects of adipsin. C3a acts on islets by augmenting ATP levels, respiration and cytosolic free Ca2+. Finally, we demonstrate that T2DM patients with β cell failure are deficient in adipsin. These findings indicate that the adipsin/C3a pathway connects adipocyte function to β cell physiology and manipulation of this molecular switch may serve as a novel therapy in T2DM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2014.06.005

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 63 references

Cited by

See all 381

Metadata

Authors
Lo, J. C., Ljubicic, S., Leibiger, B., Kern, M., Leibiger, I. B., Moede, T., Kelly, M. E., Chatterjee Bhowmick, D., Murano, I., Cohen, P., Banks, A. S., Khandekar, M. J., Dietrich, A., Flier, J. S., Cinti, S., Blüher, M., Danial, N. N., Berggren, P.-O., & Spiegelman, B. M.
Venue
Cell
Publisher
Elsevier BV
Published
2014-07
Volume
158
Issue
1
Pages
41-53
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2013710242
Cited by
381
References
63
FWCI
23.30
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adipsin Is an Adipokine that Improves β Cell Function in Diabetes. https://app.cochat.ai/papers/10.1016/j.cell.2014.06.005
The paper
Lo, J. C., Ljubicic, S., Leibiger, B., Kern, M., Leibiger, I. B., Moede, T., Kelly, M. E., Chatterjee Bhowmick, D., Murano, I., Cohen, P., Banks, A. S., Khandekar, M. J., Dietrich, A., Flier, J. S., Cinti, S., Blüher, M., Danial, N. N., Berggren, P.-O., & Spiegelman, B. M. (2014). Adipsin Is an Adipokine that Improves β Cell Function in Diabetes. Cell. https://doi.org/10.1016/j.cell.2014.06.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.